Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
8.1%
% of IHE's 38 holdings also in OZEM
12.5%
% of OZEM's 25 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 22.7% | 17.7% | 17.7% |
|
PFIZER INC | 4.5% | 3.7% | 3.7% |
|
CORCEPT THERAPEUTICS INC | 2.1% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 22.8% |
|
ELI LILLY & CO | 5.0% |
|
ZOETIS INC | 4.6% |
|
INTRA-CELLULAR THERAPIES INC | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% |
|
MERCK & CO. INC. | 4.3% |
|
ROYALTY PHARMA PLC CLASS A | 4.3% |
|
VIATRIS, INC. | 4.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.1% |
|
ELANCO ANIMAL HEALTH, INC. | 2.1% |
IHE Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -12.7% |
 |
ROCHE HOLDING LTD | -6.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
 |
INNOVENT BIOLOGICS, INC. | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
AMGEN INC | -4.7% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
HANMI PHARM CO LTD | -2.9% |
 |
THE UNITED LABORATORIES INTE | -2.7% |
|
GILEAD SCIENCES INC | -2.7% |